Jakarta – Kepolisian Negara Republik Indonesia memberikan penghargaan Indikator Kinerja Pelaksanaan Anggaran (IKPA) terbaik kepada jajaran Polda dalam rangkaian Rapat Kerja Teknis (Rakernis) Gabungan Empat Fungsi Pusat Polri Tahun 2026 di Rupattama Mabes Polri, Jakarta, Rabu (29/4/2026).

Penghargaan tersebut diberikan sebagai bentuk apresiasi atas kinerja pengelolaan anggaran yang akuntabel, efektif, dan profesional sepanjang tahun 2025.

Penghargaan diserahkan langsung oleh Wakil Kepala Kepolisian Negara Republik Indonesia (Wakapolri) Komjen Pol. Dedi Prasetyo didampingi Kapuslitbang dan Kapuskeu Polri.

Untuk kategori pagu besar, penghargaan IKPA terbaik diraih Polda Sulawesi Selatan. Sementara kategori pagu sedang diberikan kepada Polda Riau, dan kategori pagu kecil diraih Polda Kalimantan Utara.

Dalam arahannya, Wakapolri menegaskan bahwa tata kelola keuangan yang baik merupakan fondasi penting dalam mendukung keberhasilan organisasi, termasuk pelaksanaan tugas-tugas kepolisian di lapangan.

“Tidak ada satu organisasi sehebat apa pun kalau tidak didukung oleh anggaran, dan tidak dilakukan tata kelola penggunaan anggaran yang benar,” ujar Komjen Pol. Dedi Prasetyo.

Menurutnya, capaian para penerima penghargaan menunjukkan komitmen jajaran kewilayahan dalam mengelola anggaran negara secara transparan dan bertanggung jawab.

Prestasi tersebut diharapkan dapat menjadi contoh bagi satuan kerja lainnya di lingkungan Polri.

Wakapolri juga menekankan pentingnya peningkatan kualitas pengelolaan keuangan di seluruh jajaran agar mampu menjawab tantangan organisasi ke depan.

Ia menyebut profesionalisme personel pengemban fungsi keuangan harus terus diperkuat seiring tuntutan akuntabilitas publik yang semakin tinggi.

“Nilai IKPA Polri harus terus meningkat. Kita harus betul-betul memastikan tata kelola keuangan yang akuntabel, transparan, dan profesional,” katanya.

Selain penghargaan IKPA, Polri juga menyerahkan penghargaan lain berdasarkan hasil survei Puslitbang Polri Tahun 2025.

Polda Bengkulu menerima penghargaan tingkat kepuasan masyarakat terbaik, sedangkan Polda Bali meraih penghargaan internalisasi budaya integritas, kejujuran, dan kehormatan Polri.

Pemberian penghargaan tersebut menjadi bagian dari upaya Polri mendorong budaya kompetisi sehat, peningkatan kinerja, serta penguatan reformasi birokrasi di seluruh satuan kerja.

Melalui momentum Rakernis ini, Polri menegaskan komitmennya untuk terus meningkatkan kualitas pelayanan publik dan tata kelola organisasi yang modern serta terpercaya.

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.